Go Pro

Amrize (NYSE:AMRZ) Hits New 1-Year Low - Time to Sell?

Amrize logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Amrize shares fell to a new 52-week low of $46.31 after the company’s second-quarter adjusted EPS of $0.88 missed the $0.92 consensus estimate, despite revenue rising 8.6% year over year to $3.49 billion.
  • The company raised its 2026 revenue outlook to $12.5 billion-$12.7 billion and expects adjusted EBITDA of $3.1 billion-$3.2 billion, supported by demand from data centers, energy projects and infrastructure modernization.
  • Higher fuel, freight and operating costs pressured margins, but analysts remain broadly positive, with a “Moderate Buy” consensus and average price target of $62.79; insiders have also purchased approximately $2.7 million of shares in the past 90 days.
  • Interested in Amrize? Here are five stocks we like better.

Amrize Ltd (NYSE:AMRZ - Get Free Report)'s share price hit a new 52-week low during trading on Saturday . The stock traded as low as $46.31 and last traded at $46.7560, with a volume of 9530947 shares traded. The stock had previously closed at $51.22.

Key Amrize News

Here are the key news stories impacting Amrize this week:

  • Positive Sentiment: Second-quarter revenue increased 8.6% year over year to $3.49 billion, while net income rose 14.4% to $476 million. Growth was supported by demand from data centers, energy projects, advanced manufacturing and infrastructure modernization. Amrize Reports Second Quarter 2026 Results
  • Positive Sentiment: Amrize raised its 2026 revenue guidance to $12.5 billion-$12.7 billion, above the roughly $12.4 billion analyst consensus, and set adjusted EBITDA guidance at $3.1 billion-$3.2 billion. Amrize Lifts 2026 Revenue Outlook
  • Positive Sentiment: The company returned $502 million to shareholders during the quarter through $197 million of share repurchases and $305 million of dividends. Amrize also declared a quarterly dividend of $0.11 per share, payable August 26, 2026. Amrize Declares Dividend
  • Neutral Sentiment: Management cited strong demand across both Building Materials and Building Envelope, whose revenue rose 8.2% and 9.4%, respectively. Recent reports also highlighted broad insider buying, although institutional ownership changes were mixed.
  • Negative Sentiment: Adjusted earnings of $0.88 per share fell short of the $0.92 consensus estimate, creating the main near-term catalyst for selling even though earnings increased from $0.78 a year earlier. Amrize Misses Q2 Earnings Estimates
  • Negative Sentiment: Higher fuel, freight and other operating costs limited adjusted EBITDA growth to 5.8% and pressured margins. Investors may therefore question how much of the revenue growth will translate into future profit.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Royal Bank Of Canada dropped their price target on Amrize from $61.00 to $60.00 and set a "sector perform" rating on the stock in a research report on Friday, May 1st. Stephens restated an "overweight" rating and set a $65.00 price objective on shares of Amrize in a research report on Monday, May 18th. Citigroup lowered their target price on Amrize from $76.00 to $66.00 and set a "buy" rating on the stock in a research note on Monday, May 4th. Sanford C. Bernstein reiterated an "outperform" rating on shares of Amrize in a report on Monday, June 22nd. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Amrize in a report on Friday, June 26th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Amrize currently has an average rating of "Moderate Buy" and an average target price of $62.79.

Get Our Latest Stock Analysis on Amrize

Amrize Stock Performance

The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38. The firm has a 50-day simple moving average of $51.94 and a two-hundred day simple moving average of $54.72. The company has a market capitalization of $25.86 billion, a price-to-earnings ratio of 21.55, a price-to-earnings-growth ratio of 1.08 and a beta of 0.11.

Amrize (NYSE:AMRZ - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The firm had revenue of $3.49 billion for the quarter. Amrize had a return on equity of 10.17% and a net margin of 9.89%. As a group, sell-side analysts forecast that Amrize Ltd will post 2.76 earnings per share for the current fiscal year.

Amrize Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize's dividend payout ratio (DPR) is presently 21.05%.

Insider Buying and Selling at Amrize

In other Amrize news, insider Nollaig Forrest purchased 2,000 shares of the business's stock in a transaction dated Friday, May 22nd. The shares were acquired at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the acquisition, the insider owned 20,139 shares of the company's stock, valued at $1,011,984.75. This trade represents a 11.03% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CTO Roald Brouwer acquired 1,500 shares of Amrize stock in a transaction that occurred on Thursday, May 21st. The stock was acquired at an average cost of $49.84 per share, with a total value of $74,760.00. Following the purchase, the chief technology officer owned 19,757 shares in the company, valued at $984,688.88. The trade was a 8.22% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have purchased 54,918 shares of company stock worth $2,717,324. Company insiders own 0.54% of the company's stock.

Institutional Trading of Amrize

Several large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in shares of Amrize by 5.6% in the 4th quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company's stock valued at $1,722,500,000 after acquiring an additional 1,676,843 shares in the last quarter. Norges Bank acquired a new position in Amrize during the fourth quarter valued at approximately $929,333,000. Wellington Management Group LLP grew its holdings in Amrize by 48.8% during the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock valued at $561,018,000 after purchasing an additional 3,809,133 shares during the last quarter. Harris Associates L P bought a new position in shares of Amrize in the fourth quarter valued at approximately $615,406,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Amrize by 1.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,674,921 shares of the company's stock valued at $532,076,000 after purchasing an additional 156,903 shares during the period.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines